CHRNA7 and colitis: Based on the existence of zebrafish nicotinic acetylcholine receptor α7nAChR (19) as well as α7 nicotinic agonist AR-R17779’s protective effect on colitis (20), α7nAchR signaling would be a promising target to efficiently activate intestinal α7nAChR mediated anti-inflammatory function.